Morgan Stanley India Investment Fund, Inc.
NYSE:IIF
27.8 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 32.946 | -35.563 | 82.415 | 13.546 | -1.861 | -109.666 | 187.327 | 4.926 | 3.914 | 4.348 | 3.682 | 5.023 | 0 |
Cost of Revenue
| 3.278 | 3.912 | 3.992 | 3.311 | 3.78 | 5.327 | 6.563 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 29.668 | -39.475 | 78.423 | 10.235 | -5.641 | -114.993 | 180.764 | 4.926 | 3.914 | 4.348 | 3.682 | 5.023 | 0 |
Gross Profit Ratio
| 0.901 | 1.11 | 0.952 | 0.756 | 3.031 | 1.049 | 0.965 | 1 | 1 | 1 | 1 | 1 | 0 |
Reseach & Development Expenses
| 0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0.716 | 0.821 | 0.727 | 0.779 | 0.692 | 1.104 | 1.787 | 6.13 | 6.317 | 5.558 | 4.949 | 5.27 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 0.716 | 0.821 | 0.727 | 0.779 | 0.692 | 1.104 | 1.787 | 6.13 | 6.317 | 5.558 | 4.949 | 5.27 | 0 |
Other Expenses
| 19.668 | -0.139 | -0.144 | -0.105 | -0.138 | -0.215 | -0.265 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| -19.668 | 0.682 | 0.583 | 0.674 | 0.554 | 0.889 | 1.522 | 14.438 | 6.593 | 136.594 | 22.177 | 94.497 | 0 |
Operating Income
| 49.336 | -36.245 | 81.832 | 12.872 | -2.415 | -110.555 | 185.805 | -1.204 | -2.403 | -1.21 | -1.267 | -0.247 | 0 |
Operating Income Ratio
| 1.497 | 1.019 | 0.993 | 0.95 | 1.298 | 1.008 | 0.992 | -0.244 | -0.614 | -0.278 | -0.344 | -0.049 | 0 |
Total Other Income Expenses Net
| -0.048 | -0.348 | -0.287 | -0.038 | -0.381 | -0.423 | 1.87 | 20.568 | -0.276 | 142.152 | -17.228 | 99.767 | 0 |
Income Before Tax
| 49.288 | -36.245 | 81.832 | 12.872 | -2.415 | -110.555 | 185.805 | 19.364 | -2.679 | 140.942 | -18.495 | 99.52 | 0 |
Income Before Tax Ratio
| 1.496 | 1.019 | 0.993 | 0.95 | 1.298 | 1.008 | 0.992 | 3.931 | -0.684 | 32.415 | -5.023 | 19.813 | 0 |
Income Tax Expense
| -1.374 | -2.474 | -2.674 | -1.045 | -0.087 | -0.161 | 0.471 | 20.568 | -0.276 | 142.152 | -17.228 | 99.767 | 0 |
Net Income
| 49.288 | -36.245 | 81.832 | 12.872 | -2.415 | -110.555 | 185.805 | 19.364 | -2.679 | 140.942 | -18.495 | 99.52 | 0 |
Net Income Ratio
| 1.496 | 1.019 | 0.993 | 0.95 | 1.298 | 1.008 | 0.992 | 3.931 | -0.684 | 32.415 | -5.023 | 19.813 | 0 |
EPS
| 4.91 | -3.3 | 7.29 | 1.14 | -0.18 | -8.11 | 12.96 | 1.34 | -0.18 | 9.15 | -1.16 | 5.35 | 0 |
EPS Diluted
| 4.91 | -3.3 | 7.29 | 1.14 | -0.18 | -7.87 | 12.96 | 1.34 | -0.18 | 9.15 | -1.16 | 5.35 | 0 |
EBITDA
| 49.336 | -36.245 | 81.832 | 12.872 | -2.415 | -110.555 | 185.805 | 20.568 | -0.276 | 142.152 | -17.228 | 99.767 | 0 |
EBITDA Ratio
| 1.497 | 1.019 | 0.993 | 0.95 | 1.298 | 1.008 | 0.992 | 4.175 | -0.071 | 32.694 | -4.679 | 19.862 | 0 |